Cerebrovascular reserve capacity in patients with hyperlipidemia

Journal of Clinical Ultrasound

Volumn 28, Issue 3, 2000, Pages 115-121

  Kerenyi, Levente L ^a,b   Fulesdi, Bela ^a   Ficzere, Andrea ^a   Kaposzta, Zoltan ^a   Valikovics, Attila ^a   Paragh, Gyorgy ^a   Csiba, Laszlo ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Acetazolamide; Cerebrovascular reserve capacity; Cholesterol; Hyperlipidemia; Ultrasonography

Indexed keywords

ARTICLE; BLOOD FLOW VELOCITY; BLOOD VESSEL REACTIVITY; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; HUMAN; HYPERLIPIDEMIA; MIDDLE CEREBRAL ARTERY; RISK FACTOR;

ACETAZOLAMIDE; ADULT; BLOOD FLOW VELOCITY; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; HYPERLIPIDEMIAS; INJECTIONS, INTRAVENOUS; INTRACRANIAL ARTERIOSCLEROSIS; LIPIDS; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; OUTPATIENTS; RETROSPECTIVE STUDIES; RISK FACTORS; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; VASODILATION;

EID: 0034058297     PISSN: 00912751     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0096(200003/04)28:3<115::AID-JCU2>3.0.CO;2-O     Document Type: Article

References (40)

1. Wolfe PA, D'Agostino RB, Belanger AJ, et al. Probability of stroke: a risk profile from the Framingham Study. Stroke 1991;22:312.
2. Sacco RL, Kargman DE, Zamanillo MC. Race-ethnic differences in stroke risk factors among hospitalized patients with cerebral infarction: the Northern Manhattan Stroke Study. Neurology 1995;45:659.
3. Benfante R, Yano K, Hwang LJ, et al. Elevated serum cholesterol is a risk factor for both coronary heart diseases and thromboembolic stroke in Hawaiian Japanese men. Implications of shared risk. Stroke 1994;25:814.
4. Kaste M, Koivisto P. Risk of brain infarction in familial hypercholesterolemia. Stroke 1988;19: 1097-1100.
5. Konishi M, Iso H, Komachi Y, et al. Associations of serum total cholesterol, different types of stroke, and stenosis distribution of cerebral arteries. Stroke 1993;24:954.
6. Hebert PR, Gaziano JM, Hennekens CH. An overview of trials of cholesterol lowering and risk of stroke. Arch Intern Med 1995;155:50.
7. Atkins D, Psaty BM, Koepsell TD, et al. Cholesterol reduction and the risk for stroke in men. A meta-analysis of randomized, controlled trials. Ann Intern Med 1993;119:136.
8. Meyer JS, Rogers RL, Mortel KF, et al. Hyperlipidemia is a risk factor for decreased cerebral perfusion and stroke. Arch Neurol 1987;44:418.
9. 31P-NMR study. J Cereb Blood Flow Metab 1989;9:417.
10. Vorstrup S, Henriksen L, Paulson OB. Effect of acetazolamide on cerebral blood flow and cerebral metabolic rate for oxygen. J Clin Invest 1984;74: 1634.
11. Piepgras A, Schmiedek P, Leinsinger G, et al. A simple test to assess cerebrovascular reserve capacity using transcranial Doppler sonography and acetazolamide. Stroke 1990;21:1306.
12. Dahl A, Lindegaard KF, Russell D, et al. A comparison of transcranial Doppler and cerebral blood flow studies to assess cerebral vasoreactivity. Stroke 1992;23:15.
13. Gur AY, Bova I, Bornstein NM. Is impaired vasomotor reactivity a predictive factor for stroke in asymptomatic patients? Stroke 1996;27:2188.
14. Kaposzta Z, Kerenyi L, Bereczki D, et al. Evaluation of intracranial hemodynamics in severe ischemic stroke patients. In: Klingerhofer J, Bartels E, Ringelstein EB, editors. New trends in cerebral hemodynamics and neurosonology. Amsterdam: Elsevier; 1997. p 266-270.
15. Ficzere A, Valikovics A, Fülesdi B, et al. Cerebrovascular reactivity in hypertensive patients. A transcranial Doppler study. J Clin Ultrasound 1997;25:383.
16. Csiba L, Valikovics A, Fulesdi B, et al. Noninvasive diagnostics of impairment of cerebral hemodynamics in patients with stroke-risk factors. In: Klingerhofer J, Bartels E, Ringelstein EB, editors. New trends in cerebral hemodynamics and neurosonology. Amsterdam: Elsevier; 1997. p 576-583.
17. Fülesdi B, Limburg M, Bereczki D, et al. Impairment of cerebrovascular reactivity in long-term insulin-dependent diabetes mellitus. Diabetes 1997; 46:1840.
18. Csépány T, Valikovics A, Fülesdi B, et al. Transcranial Doppler may reveal asymptomatic cerebral vasculopathy in systemic lupus erythematosus. Cerebrovascular Disease 1995;5:178.
19. Rodriguez G, Bertolini S, Nobili F, et al. Regional cerebral blood flow in familial hypercholesterolemia. Stroke 1994;25:831.
20. Endarterectomy for moderate symptomatic carotid stenosis: interim results from the MRC European Carotid Surgery Trial. Lancet 1996;347:1591.
21. Ley-Pozo J, Ringelstein EB. Noninvasive detection of occlusive disease of the carotid siphon and middle cerebral artery. Ann Neurol 1990;28:640.
22. Rorick MB, Nichols FT, Adams RJ. Transcranial Doppler correlation with angiography in detection of intracranial stenosis. Stroke 1994;25:1931.
23. Gaw AJ, Bevan JA. Flow-induced relaxation of the rabbit middle cerebral artery is composed of both endothelium-dependent and -independent components. Stroke 1993;24:105.
24. Garcia-Roldan JL, Bevan JA. Flow-induced constriction and dilation of cerebral resistance arteries. Circ Res 1990;66:1445.
25. Dahl A, Russell D, Nyberg-Hansen R, et al. Simultaneous assessment of vasoreactivity using transcranial Doppler ultrasound and cerebral blood flow in healthy subjects. J Cereb Blood Flow Metab 1994;14:974.
26. 2 on extracranial flow volume and intracranial blood flow velocity. Stroke 1999;30:76.
27. Sorteberg W, Lindegaard KF, Rootwelt K, et al. Effect of acetazolamide on cerebral artery blood velocity and regional cerebral blood flow in normal subjects. Acta Neurochir (Wien) 1989;97:139.
28. Brauer P, Kochs E, Werner C, et al. Correlation of transcranial Doppler sonography mean flow velocity with cerebral blood flow in patients with intracranial pathology. J Neurosurg Anesthesiol 1998; 10:80.
29. Yamori Y, Horie R, Sato M, et al. Hypertension as an important factor for cerebrovascular atherogenesis in rats. Stroke 1976;7:120.
30. Kato H, Tokunaga O, Watanabe T, et al. Experimental cerebral atherosclerosis in the rabbit: scanning electron microscopic study of the initial lesion site. Pathol Res Pract 1991;187:797.
31. Konishi M, Iso H, Komachi Y, et al. Association of serum total cholesterol, different types of stroke and stenosis distribution of cerebral arteries. The Akita Pathology Study. Stroke 1993;24:954.
32. Mann GV, Andrus SB. Xanthomatosis and arteriosclerosis produced by diet in adult Rhesus monkey. J Lab Clin Med 1956;48:533.
33. Taylor CB, Cox GE, Manalo-Estrella P, et al. Atherosclerosis in Rhesus monkeys. II. Arterial lesions associated with hypercholesteremia induced by dietary fat and cholesterol. Arch Pathol 1962;74:16.
34. Kramsch DM, Hollander W. Occlusive atherosclerosis disease of the coronary arteries in monkey (Macaca irus) induced by diet. Exp Mol Pathol 1968;9:1.
35. Bullock BC, Clarkson TB, Lechner NMD, et al. Atherosclerosis in Cebus albifrons monkeys. III. Clinical and pathologic studies. Exp Mol Pathol 1969;10:39.
36. Mathur KS, Kashyap SK, Kumar V. Correlation of the extent and severity of atherosclerosis in the coronary and cerebral arteries. Circulation 1963; 27:929.
37. Ooneda G. Pathology of stroke. Jpn Circ J 1986;50: 1224.
38. Rubba P, Mercuri M, Faccenda F, et al. Premature carotid atherosclerosis: does it occur in both familial hypercholesterolemia and homocystinuria? Ultrasound assessment of arterial intima-media thickness and blood flow velocity. Stroke 1994;25: 943.
39. Agewall S, Fagerberg B, Attvall S, et al. Carotid artery wall intima-media thickness is associated with insulin-mediated glucose disposal in men at high and low coronary risk. Stroke 1995;26:956.
40. Szirmai IG, Kamondi A, Magyar H, et al. Relation of laboratory and clinical variables to the grade of carotid arteriosclerosis. Stroke 1993;24:1811.